GLP-1/GIP + B12

Power up your weight loss!

GLP-1/GIP + B12
helps control cravings, enhance metabolism, and deliver sustainable results—empowering you to achieve your goals with confidence.

GLP-1/GIP + B12

Premium GLP-1/GIP blend featuring a full dose of GLP-1/GIP + B12, enhanced with B Vitamins to support weight loss and boost energy levels.

Starter

$299/month

Up to 5mg

Maintenance

$399/month

Up to 7.5mg

Standard

$499/month

Up to 12.5mg

What is GLP-1/GIP + B12, and how does it work?

GLP-1/GIP + B12
is our advanced compounded medication, carefully designed to combine the benefits of GLP-1/GIP + B12
with additional supportive ingredients. Tailored for individual patient needs, this customized formulation offers a personalized therapeutic option for those who may not tolerate standard formulations or require specialized care.

GLP-1/GIP + B12
plays a crucial role in regulating blood sugar and suppressing appetite. The added supportive ingredients are selected to address common challenges associated with weight loss and diabetes treatment, such as fatigue, muscle loss, or neuropathy. These enhancements may help improve metabolic function, neurological health, and musculoskeletal strength, supporting overall wellness throughout the treatment process.

Compounded in strict compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act, GLP-1/GIP + B12
is available only with a valid, patient-specific prescription from a licensed healthcare provider. This compounded medication is not affiliated with or endorsed by Eli Lilly and is not intended as a substitute for FDA-approved products. It is exclusively prepared for patients with clinical needs that cannot be met by commercially available alternatives and is not for resale, bulk distribution, or office use.

GLP-1/GIP + B12
contains the same active ingredients as the branded version but is prepared by licensed compounding pharmacies. This allows for greater flexibility in dosing or combinations, which may not be available with the standard commercial formulation. It can also be a more affordable option for some patients.

Take Control, Crush Cravings, and Achieve Lasting Results

At Skinny Shots, we believe in a holistic approach to weight loss, prioritizing your overall health and well-being. Our approach is designed to support your body’s natural balance, empowering you to achieve lasting, sustainable results.

Setting a New Standard in
Care and Confidence

At Skinny Shots, your health and well-being are our top priorities. We work with state-regulated compounding pharmacies that uphold the highest industry standards of our compounded GLP-1 medications.

Passed Potency Test

Passed Sterility Test

PASSED pH TEST

Passed Endotoxicity Test

GLP-1 in the news

Today Show

Oprah Winfrey reveals she's using a weight-loss drug: 'Not about willpower'

The New York Times

Wegovy is shown to reduce risk of heart attacks and strokes in some patients

Fox News

Study: GLP-1 weight loss drugs could help reduce alcohol use disorder symptoms

Neurodegenerative diseases impact 8.4 million Americans, with cases on the rise.

Standard Approach

Screening usually begins only after symptoms like memory loss or confusion appear.

Our Approach

We use genetic testing and detailed family history analysis to assess risk with precision, even before symptoms develop.

Result

Identifying high-risk individuals early allows for personalized interventions like lab monitoring, dietary changes, and exercise to lower future risks.

Metabolic dysfunction impacts over 93 million U.S. adults, fueling obesity and chronic disease risk.

Standard Approach

Screenings like colonoscopies and mammograms usually begin at ages 50 and 40.

Our Approach

We start colonoscopy screenings at age 40 and use advanced tools like Full-Body MRIs, liquid biopsies, and lab tests to detect risks early.

Result

We start colonoscopy screenings at age 40 and use advanced tools like Full-Body MRIs, liquid biopsies, and lab tests to detect risks early.

Despite progress, cancer impacts 1.9 million Americans and causes over 600,000 deaths annually.

Standard Approach

Screenings like colonoscopies and mammograms usually begin at ages 50 and 40.

Our Approach

We start colonoscopy screenings at age 40 and use advanced tools like Full-Body MRIs, liquid biopsies, and lab tests to detect risks early.

Result

We start colonoscopy screenings at age 40 and use advanced tools like Full-Body MRIs, liquid biopsies, and lab tests to detect risks early.

Cardiovascular disease is the leading cause of death in the US, claiming 655,000 lives each year.

Standard Approach

Blood pressure and cholesterol screenings to evaluate heart attack risk typically begin in the 60s and 70s, focusing on a 10-year risk assessment.

Our Approach

By leveraging a 30-year risk profile, we use advanced lab tests and imaging to identify heart disease risk up to three decades in advance.

Result

Helping our patients take proactive steps to minimize their risk well before the disease develops.
Join the Longevity Insider Network

Connect with individuals committed to living healthier, longer lives.

To be included, please share your details below: